Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.70000 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Liyuan Zhong und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Angiogenesis, Infarction, Middle Cerebral Artery, Ischemic Stroke, RNA, Long Noncoding. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation, Natural Science Foundation of Beijing Municipality.
Themen: Schlaganfall
Abstract (Originalsprache)
Aims
This study aimed to explore the effects of long noncoding RNA (lncRNA) H19 knockdown on angiogenesis and blood–brain barrier (BBB) integrity following cerebral ischemia/reperfusion (I/R) and elucidate their underlying regulatory mechanisms.
Methods
A middle cerebral artery occlusion/reperfusion model was used to induce cerebral I/R injury. The cerebral infarct volume and neurological impairment were assessed using 2,3,5‐triphenyl‐tetrazolium chloride staining and neurobehavioral tests, respectively. Relevant proteins were evaluated using western blotting and immunofluorescence staining. Additionally, a bioinformatics website was used to predict the potential target genes of lncRNA H19. Finally, a rescue experiment was conducted to confirm the potential mechanism.
Results
Silencing of H19 significantly decreased the cerebral infarct volume, enhanced the recovery of neurological function, mitigated BBB damage, and stimulated endothelial cell proliferation following ischemic stroke. Insulin‐like growth factor 2 mRNA‐binding protein 2 (IMP2) is predicted to be a potential target gene for lncRNA H19. H19 knockdown increased IMP2 protein expression and IMP2 inhibition reversed the protective effects of H19 inhibition.
Conclusion
Downregulation of H19 enhances angiogenesis and mitigates BBB damage by regulating IMP2, thereby alleviating cerebral I/R injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Cerebrovascular Disease Research and Department of Neurology, Xuanwu Hospital of Capital Medical University, Beijing, China.
- Beijing Geriatric Medical Research Center and Beijing Key Laboratory of Translational Medicine for Cerebrovascular Diseases, Beijing, China.
ORCID-Profile: Liyuan Zhong, Yumin Luo
Förderung
- National Natural Science Foundation of China
- Beijing Municipal Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhong, L., Fan, J., Yan, F., Yang, Z., Hu, Y., Li, L., Wang, R., Zheng, Y., Luo, Y., & Liu, P. (2024). Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70000
Vancouver
Zhong L, Fan J, Yan F, Yang Z, Hu Y, Li L, et al. Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70000
BibTeX
@article{Zhong2024,
author = {Zhong, Liyuan and Fan, Junfen and Yan, Feng and Yang, Zhenhong and Hu, Yue and Li, Lingzhi and Wang, Rongliang and Zheng, Yangmin and Luo, Yumin and Liu, Ping},
title = {Long noncoding RNA H19 knockdown promotes angiogenesis via IMP2 after ischemic stroke},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.70000}
}
EUVIMED